With a powerful rival still in the lead, Valencia-based MannKind has hired some talent away from some of the world's top pharmaceutical businesses to help it push forward in its efforts to get its Technosphere inhaled insulin to market...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 26 biweekly issues
  • Subscriber-only digital content for prime stories
  • Book of Lists — the most comprehensive business resource in the Valley region
Yours for only $49